INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 3 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $265,000 | -70.7% | 115 | -39.2% | 0.01% | -83.9% |
| Q2 2020 | $905,000 | +75.4% | 189 | +130.5% | 0.06% | +44.2% |
| Q1 2020 | $516,000 | -58.8% | 82 | -18.8% | 0.04% | -60.6% |
| Q4 2019 | $1,251,000 | -29.2% | 101 | -36.1% | 0.11% | -36.3% |
| Q1 2019 | $1,767,000 | -33.9% | 158 | -40.4% | 0.17% | -56.0% |
| Q4 2018 | $2,672,000 | +54.4% | 265 | +93.4% | 0.39% | +127.5% |
| Q3 2018 | $1,731,000 | +145.5% | 137 | +63.1% | 0.17% | +180.3% |
| Q2 2018 | $705,000 | – | 84 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 189 | $905,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 109,500 | $5,246,000 | 0.02% |
| SIMPLEX TRADING, LLC | 354 | $1,696,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |